243 related articles for article (PubMed ID: 14626500)
1. Antifungal pharmacotherapy for neonatal candidiasis.
Bliss JM; Wellington M; Gigliotti F
Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
[TBL] [Abstract][Full Text] [Related]
2. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
3. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Fanci R
J Chemother; 2009 Feb; 21(1):105-7. PubMed ID: 19297283
[No Abstract] [Full Text] [Related]
6. Voriconazole for candidosis: an important addition?
Graybill JR
Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
[No Abstract] [Full Text] [Related]
7. Antifungals in systemic neonatal candidiasis.
Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
[TBL] [Abstract][Full Text] [Related]
8. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
9. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
10. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin in a pediatric patient with persistent candidemia.
Wertz KK; Pretzlaff RK
Pediatr Crit Care Med; 2004 Mar; 5(2):181-3. PubMed ID: 14987350
[TBL] [Abstract][Full Text] [Related]
12. [Systemic antifungal agents].
Lumbreras C; Lizasoain M; Aguado JM
Enferm Infecc Microbiol Clin; 2003; 21(7):366-79; quiz 380, 390. PubMed ID: 14525693
[TBL] [Abstract][Full Text] [Related]
13. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
[TBL] [Abstract][Full Text] [Related]
14. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC
Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
[TBL] [Abstract][Full Text] [Related]
15. Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Ericson J; Manzoni P; Benjamin DK
Early Hum Dev; 2013 Jun; 89 Suppl 1(0 1):S25-7. PubMed ID: 23809344
[TBL] [Abstract][Full Text] [Related]
16. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
17. New options for the treatment of invasive fungal infections.
Rubin ZA; Somani J
Semin Oncol; 2004 Apr; 31(2 Suppl 4):91-8. PubMed ID: 15124141
[TBL] [Abstract][Full Text] [Related]
18. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
19. [New antifungal agents: voriconazole and caspofungin].
Dupont B
Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
McGee WT; Tereso GJ
Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
